STUDY ON THE EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SLOVAKIA: ONE YEAR RESULTS OF PROSPECTIVE, OPEN LABEL STUDY CLOSE TO CLINICAL PRACTICE

被引:0
|
作者
Rybar, I. [1 ]
Killinger, Z. [2 ]
Macejova, Z. [3 ]
Kmecova, Z. [4 ]
Zanova, E. [5 ]
Rovensky, J. [5 ]
机构
[1] Slovak Med Univ, Dept Rheumatol, Piestany, Slovakia
[2] Comenius Univ, Sch Med, Dept Internal Med 5, Bratislava, Slovakia
[3] Safarik Univ, Sch Med, Dept Internal Med 1, Kosice, Slovakia
[4] Slovak Med Univ, Dept Internal Med 2, Banska Bystrica, Slovakia
[5] Slovak Med Univ, Dept Rheumatol, Bratislava, Slovakia
关键词
D O I
10.1136/annrheumdis-2014-eular.1516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0428
引用
收藏
页码:948 / 949
页数:2
相关论文
共 50 条
  • [1] Tocilizumab in Patients with Active Rheumatoid Arthritis and Inadequate Response to DMARDs and/or TNF Inhibitors: A Large, Open-Label Study Close to Clinical Practice
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2012, 19 (04): : 195 - 195
  • [2] Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
    Bykerk, Vivian P.
    Ostor, Andrew J. K.
    Alvaro-Gracia, Jose
    Pavelka, Karel
    Ivorra, Jose Andres Romon
    Graninger, Winfried
    Bensen, William
    Nurmohamed, Michael T.
    Krause, Andreas
    Bernasconi, Corrado
    Stancati, Andrea
    Sibilia, Jean
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) : 1950 - 1954
  • [3] Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice
    Bykerk, Vivian P.
    Ostor, Andrew J. K.
    Alvaro-Gracia, Jose
    Pavelka, Karel
    Roman Ivorra, Jose Andres
    Nurmohamed, Michael T.
    Luder, Yves
    Sidiropoulos, Paris N. M.
    Devenport, Jenny
    Sibilia, Jean
    CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2411 - 2421
  • [4] Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice
    Vivian P. Bykerk
    Andrew J. K. Östör
    José Alvaro-Gracia
    Karel Pavelka
    José Andrés Román Ivorra
    Michael T. Nurmohamed
    Yves Luder
    Paris N. M. Sidiropoulos
    Jenny Devenport
    Jean Sibilia
    Clinical Rheumatology, 2019, 38 : 2411 - 2421
  • [5] TOCILIZUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL CLINICAL PRACTICE: RESULTS OF TRUST STUDY
    Gerli, R.
    Afeltra, A.
    Bagnato, G.
    Carlino, G.
    Foti, R.
    Mazzone, A.
    Minisola, G.
    Pappone, N.
    Russo, R.
    Semeraro, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 682 - 683
  • [6] Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study
    Isaacs, John D.
    Salih, Abdelrazig
    Sheeran, Thomas
    Patel, Yusuf, I
    Douglas, Karen
    McKay, Neil D.
    Naisbett-Groet, Barbara
    Choy, Ernest
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2019, 3 (01)
  • [7] Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East
    Hammoudeh, Mohammed
    Adel, Al Awadhi
    Hasan, Eman Haji
    Akhlaghi, Maassoumeh
    Ahmadzadeh, Arman
    Abdollahi, Bahar Sadeghi
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2015, 2015
  • [8] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: TWO YEARS' EXPERIENCE
    Quesada-Masachs, Estefania
    Carolina Diaz, Ana
    Avila, Gabriela
    Acosta, Isabel
    Sans, Xavier
    Alegre, Cayetano
    Marsal, Sara
    RHEUMATOLOGY, 2012, 51 : 137 - 137
  • [9] Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study
    Caporali, R.
    Idolazzi, L.
    Bombardieri, S.
    Ferraccioli, G.
    Gerli, R.
    Govoni, M.
    Cerinic, M. Matucci
    Pomponio, G.
    Salaffi, F.
    Tirri, R.
    Benaglio, F.
    Bianchino, L.
    Sarzi-Puttini, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 919 - 928
  • [10] Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)
    Yamanaka, Hisashi
    Tanaka, Yoshiya
    Inoue, Eisuke
    Hoshi, Daisuke
    Momohara, Shigeki
    Hanami, Kentaro
    Yunoue, Naoki
    Saito, Kazuyoshi
    Amano, Kouichi
    Kameda, Hideto
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 122 - 133